Holly Rodin
About
In The Last Decade
Holly Rodin
27 papers receiving 233 citations
Peers
Comparison fields: 5 of 68
- General Health Professions 93
- Economics and Econometrics 75
- Epidemiology 52
- Hepatology 38
- Health 38
Countries citing papers authored by Holly Rodin
This map shows the geographic impact of Holly Rodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Rodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Rodin more than expected).
Fields of papers citing papers by Holly Rodin
This network shows the impact of papers produced by Holly Rodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Rodin. The network helps show where Holly Rodin may publish in the future.
Co-authorship network of co-authors of Holly Rodin
This figure shows the co-authorship network connecting the top 25 collaborators of Holly Rodin. A scholar is included among the top collaborators of Holly Rodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Rodin. Holly Rodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 10 | |
| 7 | SINGLE CENTER ASSESSMENT OF LIVER INJURY AND MORTALITY BASED ON RACE AND ETHNICITY IN INDIVIDUALS WITH COVID-19 | 2 |
| 8 | 16 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | Retail clinic versus office setting: do patients choose appropriate providers? | 10 |
| 13 | Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit. | 17 |
| 14 | 5 | |
| 15 | 3 | |
| 16 | 19 | |
| 17 | 30 | |
| 18 | 51 | |
| 19 | 8 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.